The present study revealed that DPP‐4 inhibition reduces left ventricular stiffening in a rat model of combined type 2 diabetes, hypertension, and obesity, in part by modulating titin cleavage, isoform switching, and phosphorylation. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.